Evidence map›Paper›PMID 39757184›Full record

ArticleBMC surgery2025

Navigating complex arterial reconstruction in living donor liver transplantation: the role of the splenic artery as a viable conduit.

Hosam Hamed, Mohamed Elshobary, Tarek Salah, Ahmad M Sultan, El-Sayed Abou El-Magd, Ahmed M Elsabbagh, Ahmed Shehta, Mohamed Abdulrazek, Waleed Elsarraf, Mohamed A Elmorshedi and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hosam HamedLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Mohamed ElshobaryLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Tarek SalahLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Ahmad M SultanLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
El-Sayed Abou El-MagdLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Ahmed M ElsabbaghLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Ahmed ShehtaLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Mohamed AbdulrazekLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt. mohammad_maaty@mans.edu.eg.
Waleed ElsarrafLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Anesthesia Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Mohamed A ElmorshediLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Anesthesia Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Mostafa AbdelkhalekLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Anesthesia Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Usama ShihaLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Radiology Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Hassan Magdy Abd El RazekLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Radiology Department, Mansoura University, Mansoura, Dakahleyya, Egypt.
Mohamed Abdel WahabLiver Transplant Unit, Gastrointestinal Surgical Center (GISC), Surgery Department, Mansoura University, Mansoura, Dakahleyya, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn living donor liver transplantation (LDLT), maintaining hepatic arterial flow is critical for graft survival. Alternative methods are required when the recipient's hepatic artery is unsuitable due to extensive dissection or inadequate flow. This study evaluates the efficacy and safety of splenic artery transposition (SAT) for hepatic arterial reconstruction in LDLT.

methodsThis retrospective cohort study included 10 LDLT patients with hepatic arterial reconstruction by SAT to assess operative parameters, postoperative complications, mortality, and patency rate.

resultsThe splenic artery was used because of arterial dissection (70%) or inadequate arterial blood flow. Operative time ranged from 640 to 1020 min, and no splenic infarction was observed. Post-operative complications were as follows; biliary leakage (10%), pancreatitis (10%), intraabdominal hemorrhage (10%), and arterial thrombosis (10%). Mortality in this cohort was 30%, one of them was due to thrombosis of the conduit and the other two died from sepsis-related complications. With a median follow-up of 43 months, this technique was associated with a 70% survival rate.

conclusionThe splenic artery is a viable conduit for hepatic arterial reconstruction in LDLT, demonstrating an acceptable safety profile and complication rates. This approach is recommended in cases where the recipient's hepatic artery is significantly compromised.

Indexed as

Hepatic ArteryLiver TransplantationLiving DonorsSplenic ArteryAdultFemaleGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesTreatment OutcomeVascular PatencyVascular Surgical ProceduresHepatic arteryLiving donor liver transplantationReconstructionSplenic artery

Identifiers

PMID39757184
PMCPMC11702025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.